Clinical trial
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid…
NCT00107458 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00107458 |
|---|---|
| Title | Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
| Official title | A Phase I Study of Valproic Acid in Children With Recurrent/Progressive Solid Tumors Including CNS Tumors |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | valproic acid |
| Enrollment | 26 |
| Start date | May 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Mar 1, 2012 |
| First posted | Apr 6, 2005 |
| Last update posted | Aug 7, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: